NCT06512961

Brief Summary

Blood flow restriction (BFR) is a widely studied technique that combines low-intensity exercise with vascular occlusion, resulting in muscular benefits. However, its application is challenging due to methodological variations and equipment costs. Tissue Flossing (TF) appears as an affordable alternative, but lacks solid scientific evidence.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Aug 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Aug 2024Jul 2026

First Submitted

Initial submission to the registry

June 25, 2024

Completed
27 days until next milestone

First Posted

Study publicly available on registry

July 22, 2024

Completed
10 days until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2026

Last Updated

February 13, 2026

Status Verified

February 1, 2026

Enrollment Period

1.9 years

First QC Date

June 25, 2024

Last Update Submit

February 12, 2026

Conditions

Keywords

Tissue flossingBlood flow restriction

Outcome Measures

Primary Outcomes (15)

  • Occlusion pressures (AOP, 80% and 40% of AOP)

    To determine the AOP, the Doppler equipment transducer will be used, which will be positioned over the brachii artery to capture the auscultatory pulse. A blood pressure cuff will be fixed to the participant's thigh close to the region of the inguinal fold of the dominant limb, and then with the inflatable region of the cuff on the medial portion of the thigh covering the femoral artery, it will be progressively inflated, waiting 15 seconds every 30 mmHg until the point at which the auscultatory pulse of the brachii artery is interrupted.

    3 days

  • Assessment of arterial flow and diameter

    A Sonoline Sienna® vascular ultrasound will be used combined with a 40mm B-mode ultrasonic transducer with a 7.5 MHz linear beam, which will be coated with gel for acoustic contact and positioned longitudinally to the posterior brachii artery, enabling variables to be assessed. Doppler flow measurements of upper limb (peak systolic velocity \[cm/s\], end-diastolic velocity \[cm/s\] and arterial diameter).

    3 days

  • Perceptual parameter

    The perceptual parameter will be evaluated using a Borg CR10+ scale, representing the perception of discomfort, 0 represents no discomfort and 10 extremely uncomfortable.

    3 days

  • Tissue Flossing Assessment

    The application of tissue flossing on the leg will be carried out by always passing the elastic tape with 50% of the tape over the next strip, until the end of the elastic tape.

    3 days

  • Weight

    It will be collected with a weight balance

    3 days

  • Height

    It will be collected with a stadiometer

    1 day

  • Body Fat

    It will be collected with a adipometer

    1 day

  • Arterial pressure

    It will be collected with a sphygmomanometer

    1 day

  • Perimetry of the dominant upper limb

    It will be defined by the Waterloo Footedness

    1 day

  • Limb length

    Identified with a measuring tape

    1 day

  • Perceived exertion scale

    Adapted BORG scale, with 0 being "no effort" and 10 "maximum effort".

    up to 15 weeks

  • Method preference

    Participants must answer a brief questionnaire about their preference for one of the BFR methods carried out, and justify why they chose it.

    up to 15 weeks

  • 1 Maximum Repetition Test

    The warm-up will include a series of 6 to 10 repetitions, using approximately 50% of the estimated load for the first attempt of the test (44). This warm-up will not only prepare participants but also familiarize them with the movement. The determination of the initial warm-up load will be made subjectively by the researcher responsible for the study, considering the participant's height, body mass and training experience as reference points (45). After the warm-up phase, up to five attempts will be given to find the 1RM, with intervals of 3 to 5 minutes between them (46). The load adjustment for subsequent attempts will be determined by the subjective perception of effort, according to the BORG scale, where the greater the perception of effort, the lower the percentage of load added for the next attempt. The 1RM will be established as the maximum load at which the participant can perform one repetition without compensation.

    up to 15 weeks

  • Myotonometry

    Myotonometry will be assessed using the MyotonPRO® tool, which consists of a portable, wireless and non-invasive device. The measurement will be carried out once, and in each shot, the following myotonometry parameters will be calculated: the state of tension (tone) and biomechanical properties (rigidity and elasticity).

    up to 15 weeks

  • Ultrasound

    The assessment of the muscular structure will be carried out using ultrasound images of the participant's upper limbs, which will be captured using BodyMetrix BX-2000. Participants will be assessed in the supine position with arms fully extended and muscles relaxed. The ultrasound transducer will be covered with water-soluble transmission gel and positioned perpendicular to the skin over the muscle.

    up to 15 weeks

Study Arms (2)

Group Traditional BFR

ACTIVE COMPARATOR

This group will perform the training protocol with traditional BFR, using a pressure cuff as an occluder on both arms.

Device: Blood Flow Restriction CuffOther: Training Protocol

Group BFR TF

EXPERIMENTAL

This group will perform the training protocol with BFR using TF on both arms.

Device: Tissue FlossingOther: Training Protocol

Interventions

Inflatable device that exerts an external pressure above a muscle or joint of the extremities.

Group Traditional BFR

The upper limb resistance training protocol will follow that recommended in the study by Patterson et al. for resistance training, and will last 15weeks, with 3 training sessions per week, with a day break between sessions.

Group BFR TFGroup Traditional BFR

Tissue Flossing ia a elastic band that when applied exerts an external pressure above or below a muscle or joint of the extremities.

Group BFR TF

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Individuals who present one or more of the following characteristics will not be included:
  • presence of any health condition that contraindicates or prevents exercise;
  • diabetes and diagnosed high blood pressure;
  • inflammatory, psychiatric, cardiovascular and/or respiratory rheumatological disease; - -4 being dependent on alcohol, consuming drugs and/or being a smoker;
  • history of knee surgery (e.g., meniscal repair and ligament reconstruction) or recent upper limb musculoskeletal injury that may impair performance during tests or interventions (e.g., muscle injury, tendinopathy, patellofemoral pain and/or back pain column in the last six months);
  • use of ergogenic supplements to improve physical performance and/or muscle mass and/or vasoactive medications;
  • having one or more risk factors predisposing to thromboembolism

You may not qualify if:

  • Participants will be excluded from the study if they:
  • have a health problem that does not allow them to continue;
  • wish to leave the study;
  • not sign the consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UNESP

Presidente Prudente, São Paulo, 19060900, Brazil

Location

MeSH Terms

Conditions

Hypertrophy

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 25, 2024

First Posted

July 22, 2024

Study Start

August 1, 2024

Primary Completion (Estimated)

June 15, 2026

Study Completion (Estimated)

July 15, 2026

Last Updated

February 13, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations